• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Uptake of novel oral anticoagulants in Australia.

作者信息

Pratt Nicole L, Ramsay Emmae N, Caughey Gillian E, Shakib Sepehr, Roughead Elizabeth E

机构信息

University of South Australia, Adelaide, SA

University of South Australia, Adelaide, SA.

出版信息

Med J Aust. 2016 Feb 15;204(3):104-5.e1. doi: 10.5694/mja15.01000.

DOI:10.5694/mja15.01000
PMID:26866544
Abstract
摘要

相似文献

1
Uptake of novel oral anticoagulants in Australia.澳大利亚新型口服抗凝药的使用情况。
Med J Aust. 2016 Feb 15;204(3):104-5.e1. doi: 10.5694/mja15.01000.
2
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.心房颤动患者使用直接口服抗凝剂的依从性及治疗结果：退伍军人健康管理局的研究发现
BMC Cardiovasc Disord. 2017 Sep 2;17(1):236. doi: 10.1186/s12872-017-0671-6.
3
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.华法林与四种非维生素K拮抗剂口服抗凝剂用于卒中二级预防时的复发卒中量及预后分析
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):338-345. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.007. Epub 2017 Oct 13.
4
Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation.新型口服抗凝剂用于心房颤动患者卒中预防的成本效益分析的系统评价
Rev Port Cardiol. 2015 Mar;34(3):179-91. doi: 10.1016/j.repc.2014.08.008. Epub 2015 Feb 27.
5
Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study.以色列心房颤动患者非维生素K拮抗剂口服抗凝剂剂量的适宜性：一项基于人群的研究。
Thromb Res. 2018 Sep;169:140-142. doi: 10.1016/j.thromres.2018.07.024. Epub 2018 Jul 25.
6
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.非维生素K口服抗凝药用于非瓣膜性心房颤动的相对疗效和安全性：在三个患者亚组中比较阿哌沙班、达比加群、利伐沙班和依度沙班的网状Meta分析
Int J Cardiol. 2016 Feb 1;204:88-94. doi: 10.1016/j.ijcard.2015.11.084. Epub 2015 Nov 17.
7
Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.阿哌沙班、达比加群、利伐沙班和华法林在新诊断房颤中的有效性和安全性比较。
Am J Cardiol. 2017 Nov 15;120(10):1813-1819. doi: 10.1016/j.amjcard.2017.07.092. Epub 2017 Aug 8.
8
Which oral anticoagulant for atrial fibrillation.用于心房颤动的口服抗凝剂该如何选择。
Med Lett Drugs Ther. 2016 Apr 11;58(1492):45-6.
9
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.低剂量非维生素K拮抗剂口服抗凝药与华法林在房颤患者中的有效性和安全性：倾向评分加权的全国队列研究
BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.
10
Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.接受心房颤动消融术患者使用阿哌沙班、利伐沙班和达比加群的情况。
J Cardiovasc Electrophysiol. 2016 Feb;27(2):147-53. doi: 10.1111/jce.12856. Epub 2015 Nov 23.

引用本文的文献

1
Early Surgical Fixation for Hip Fractures in Patients Taking Direct Oral Anticoagulation: A Retrospective Cohort Study.接受直接口服抗凝治疗的患者髋部骨折的早期手术固定：一项回顾性队列研究
Geriatr Orthop Surg Rehabil. 2020 Jul 27;11:2151459320944854. doi: 10.1177/2151459320944854. eCollection 2020.
2
The Characteristics of Patients With Possible Transient Ischemic Attack and Minor Stroke in the Hunter and Manning Valley Regions, Australia (the INSIST Study).澳大利亚亨特和曼宁谷地区可能患有短暂性脑缺血发作和轻度中风患者的特征（INSIST研究）
Front Neurol. 2020 May 15;11:383. doi: 10.3389/fneur.2020.00383. eCollection 2020.
3
Direct Oral Anticoagulants and Timing of Hip Fracture Surgery.
直接口服抗凝剂与髋部骨折手术时机
J Clin Med. 2020 Jul 12;9(7):2200. doi: 10.3390/jcm9072200.
4
Supporting anticoagulant treatment decision making to optimise stroke prevention in complex patients with atrial fibrillation: a cluster randomised trial.支持抗凝治疗决策以优化复杂心房颤动患者的卒中预防：一项集群随机试验。
BMC Fam Pract. 2020 Jun 8;21(1):102. doi: 10.1186/s12875-020-01175-0.
5
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.静脉血栓栓塞症抗凝延长治疗患者换用直接口服抗凝剂后对患者满意度的影响：SWAN 研究。
PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020.
6
Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants.新型口服抗凝药物上市后，澳大利亚的抗凝药物使用量和支出迅速大幅增加。
PLoS One. 2018 Dec 6;13(12):e0208824. doi: 10.1371/journal.pone.0208824. eCollection 2018.
7
Influence of stroke and bleeding risk on prescribing of oral anticoagulants in older inpatients; has the availability of direct oral anticoagulants changed prescribing?中风和出血风险对老年住院患者口服抗凝剂处方的影响；直接口服抗凝剂的可获得性是否改变了处方？
Ther Adv Drug Saf. 2018 Feb;9(2):113-121. doi: 10.1177/2042098617747835. Epub 2017 Dec 20.
8
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study.接受抗血栓治疗的心房颤动患者与出血相关的住院情况：塔斯马尼亚心房颤动（TAF）研究结果
Eur J Clin Pharmacol. 2017 Dec;73(12):1681-1689. doi: 10.1007/s00228-017-2337-9. Epub 2017 Sep 22.
9
Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events.阿哌沙班、伴随用药与出血事件的自发报告
Ther Adv Drug Saf. 2017 May;8(5):157-164. doi: 10.1177/2042098616689771. Epub 2017 Feb 10.
10
Age-dependency of prescribing patterns of oral anticoagulant drugs in Austria during 2011-2014.2011 - 2014年奥地利口服抗凝药物处方模式的年龄依赖性
J Thromb Thrombolysis. 2016 Oct;42(3):447-51. doi: 10.1007/s11239-016-1380-1.